Main Sector
Pharma (fully integrated)
Subsectors
Antibodies
Drug delivery
Nucleic acid drugs
Peptides
Proteins
Small molecule therapeutics
Stem cells
Immunotherapy
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Digestive system / gastroenterology
Genitourinary system / Urology
Pregnancy, childbirth and the puerperium / obstetrics
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
External causes of morbidity and mortality / traumatology
Social circumstances / substance related disorders / addiction
Products
In development: 40
On the market: 12
Description
Novo Nordisk operates as a healthcare company involved in the design and production of pharmaceutical products. The company’s activities are categorized into two segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment includes the production of insulin, GLP-1 receptor agonists, oral antidiabetic products (OAD), and treatments for obesity and other chronic conditions, as well as the development of delivery systems for these medications. The Rare Disease...
